Submit a manuscript Sign up for article alerts Contact us Support

About ETSM

This page includes information about the aims and scope of ETSM, editorial policies, open access and article-processing charges, the peer review process and other information. For details of how to prepare and submit a manuscript through the online submission system, please see the instructions for authors.

Aims & scope

Experimental & Translational Stroke Medicine has temporarily paused publication and will re-launch in early 2016 with a revised scope encompassing more clinical research alongside its existing focus on experimental and translational stroke research.

Submissions to the journal are still welcomed, but authors should be aware that any manuscript editorially accepted will be held for publication until the time of re-launch in early 2016. Please contact with any questions.

Experimental & Translational Stroke Medicine is an open access journal presenting original research, review and comment articles on any topic that relates to identifying and solving problems in experimental, translational and clinical stroke research and related cerebrovascular diseases.

By offering a high-visibility forum for new insights and discussions, the journal helps improve the quality of experimental stroke research in order to increase the rate of successful translation of innovative treatment strategies into clinical practice.

ETSM considers studies related to all areas of stroke research, from molecular neuroscience to clinical management and rehabilitation, as well as research on other aspects of cerebrovascular medicine and disease related to stroke and cerebral hypoxia. ETSM welcomes research on topics including but not limited to:

• Neuroregeneration and repair
• Stem cell research
• Neuroprotection
• Neuroimaging
• Neuroimmunology
• Subarachnoid haemorrhage
• Genome-wide association studies
• Epidemiology
• Pharmacology
• Rehabilitation
• Physiotherapy and care
• Occupational therapy
• Speech-language therapy
• Stroke complications and disabilities
• Stroke prevention

Open access

All articles published by ETSM are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.

Authors of articles published in ETSM are the copyright holders of their articles and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the article, according to the BioMed Central copyright and license agreement.

For authors who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.

Article-processing charges

Open access publishing is not without costs. ETSM therefore levies an article-processing charge of £1370/$2145/€1745 for each article accepted for publication. If the corresponding author's institution is a Member, the cost of the article-processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are Supporter Members, however, a discounted article-processing charge is payable by the author. We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.

Indexing services

All articles published in ETSM are included in PubMed, the most widely used biomedical bibliographic database service, which is run by the US National Library of Medicine. Other bibliographic databases that index articles published in ETSM include:

  • CAS
  • Citebase
  • DOAJ
  • Embase
  • Google Scholar
  • OAIster
  • PubMed
  • PubMed Central
  • Scopus
  • Zetoc

The full text of all research articles is deposited in PubMed Central, the US National Library of Medicine's full-text repository of life science literature, and other digital archives including e-Depot (The Netherlands).

The full text of all research articles published by BioMed Central is also available on SpringerLink.

BioMed Central is working closely with Thomson Reuters (ISI) to ensure that citation analysis of articles published in ETSM will be available.

Publication and peer review process

Criteria for publication

ESTM considers the following types of articles:

  • Research articles: reports of data from original research.
  • Commentaries: short, focused and opinionated articles on any subject within the journal's scope. These articles are usually related to a contemporary issue, such as recent research findings, and may be commissioned from opinion leaders in the field.
  • Reviews: comprehensive, authoritative, descriptions of any subject within the journal's scope. Opinion leaders that have been invited by the Editorial Board usually write these articles. They have an educational aim and are 2000-3000 words.
  • Short reports: brief reports of data from original research, usually about 1500 words.
  • Letters to the Editor: they can take three forms: a substantial re-analysis of a previously published article, or a substantial response to such a re-analysis from the authors of the original publication, or an article that may not cover 'standard research' but that may be relevant to readers.

Peer-review policies

ETSM operates a closed peer-review system. Manuscripts submitted to the journal will be evaluated initially by the Editor-in-Chief or Handling Editors, and appropriate manuscripts then sent for peer review to recognized experts in the field, who may be members of the Editorial Board or external peer reviewers. The reports of at least two reviewers will be considered when deciding on acceptance or rejection of a manuscript; a further reviewer will be invited in cases where these reviewers disagree. Final decisions, however, rest with the Handling Editors or Editor-in-Chief, who aim to provide an initial decision within six weeks. In cases where authors challenge an Editors' negative decision with well-founded arguments, the manuscript can be sent to one or two additional reviewers at the discretion of the Handling Editor, and a final decision will be made upon their recommendations.

Authors will be able to check the progress of their manuscript through the submission system at any time by logging into My Experimental & Translational Stroke Medicine, a personalized section of the site.


High-quality, bound reprints can be purchased for all articles published. Please see our reprints website for further information about ordering reprints.


ETSM will consider supplements based on proceedings (full articles or meeting abstracts), reviews or research. All articles submitted for publication in supplements are subject to peer review. Published supplements are fully searchable and freely accessible online and can also be produced in print. All full length articles (proceedings, reviews or research articles) are indexed by PubMed. PubMed displays the title of the supplement only in the case of meeting abstract collections. For further information, please contact us.

Editorial policies

All manuscripts submitted to ETSM should adhere to BioMed Central's editorial policies.

Citing articles in ETSM

Articles in ETSM should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.

Article citations follow this format:

Authors: Title. Exp Transl Stroke Med [year], [volume number]:[article number].

e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Exp Transl Stroke Med 2009, 1:115.

refers to article 115 from Volume 1 of the journal.

Why publish your article in ETSM?

High visibility

ETSM's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience. Articles that have been especially highly accessed are highlighted with a 'Highly accessed' graphic, which appears on the journal's contents pages and search results.

Speed of publication

ETSM offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF; the article will then be available through ETSM, BioMed Central and PubMed Central and will also be included in PubMed.


Online publication in ETSM gives authors the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).

Promotion and press coverage

Articles published in ETSM are included in article alerts and regular email updates. Some may be included in abstract books mailed to academics and are highlighted on ETSM's pages and on the BioMed Central homepage.

In addition, articles published in ETSM may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in ETSM. A list of articles recently press-released by journals published by BioMed Central is available here.

Authors of articles published in ETSM retain the copyright of their articles and are free to reproduce and disseminate their work (for further details, see the BioMed Central copyright policy and license agreement).

For further information about the advantages of publishing in a journal from BioMed Central, please click here.